The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Insightful Insights, IVO, Precision Toxicology and Efficacy News The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Ovarian cancer is the most lethal gynecological cancer in the [...] Jack Crawford2022-02-16T09:52:11+00:00Tags: Immunodeficient Rats, TCGA, The Cancer Genome Atlas, NSG Mice, Chemo-induced stemness, Analise DiFeo, gynecological Cancer, ovarian cancer, OV81.2, OV81, Cancer Xenografts, drug resistance, in vivo model, Humanized Rats, Cell Line Xenografts, Xenografts, Oncology, OncoRat, drug discovery, rat model, Cancer, Hera Biolabs, oncology models, preclinical| Read More